Browsing Category

Supplier News

195 posts

The latest developments from suppliers of ingredients, development and manufacturing services, and related technologies for pharmaceutical and biopharmaceutical development and production.

From DCAT Week 2023: Flamma Investing $200 M for Small-Molecule API Expansions 
By

By
The Flamma Group, a CDMO of small-molecule active pharmaceutical ingredients (APIs) and advanced cGMP intermediates, is proceeding with a $200-million investment plan over the next three years to expand its…

From DCAT Week 2023: Catalent Outlines $652 M-Plus Expansion Plan, Including Integration of $475-M Acquisition of Metrics Contract Services  
By

By
Catalent has made a series of strategic investments totaling $652 million-plus to enhance the company capabilities in oral prescription and biologic products. Sherief Shaaban, Vice President, Strategic Ventures & Global…

From DCAT Week 2023: BSP Pharmaceuticals Details $349-M Expansion Plan 
By

By
BSP Pharmaceuticals, a Latina, Italy-based CDMO of cytotoxic and non-cytotoxic products, is investing EUR 320 million ($349 million) to expand its site in Latina, Italy, with the expansions slated for…

From DCAT Week 2023: Bachem Proceeds with Billion-Dollar Plus Investment Plan
By

By
Bachem, a Bubendorf, Switzerland-headquartered CDMO of peptides and oligonucleotides, is proceeding with a billion-dollar plus investment plan to increase manufacturing capacity across its sites, including new facilities. Dr. Torsten Wöhr,…

Test: FDA Scorecard: Drug Shortages and Inspections
By

By
How has the FDA performed in mitigating drug shortages and in its inspection activity since the COVID-19 pandemic? Has it been able to keep drug shortages down and keep pace with its inspection activity on levels on par pre-pandemic? Two recent reports tell the story.

Test: Pfizer To Acquire Biohaven Pharmaceuticals for $11.6 Bn
By

By
Pfizer has agreed to acquire Biohaven Pharmaceuticals, a bio/pharmaceutical company with lead assets for treating migraines, for approximately $11.6 billion. The pending acquisition follows the completion of a $1.24-billion licensing…

DCAT Week 2022: Supplier News Roundup: Formulation Development, Drug-Product Mfg & Packaging
By

By
As part of the DCAT Member Company Announcement Forum, held on March 21, 2022, at DCAT Week, the flagship event of the Drug, Chemical & Associated Technologies Association (DCAT), DCAT…

DCAT Week 2022: Supplier News Roundup: Chemicals & Chemical API Mfg
By

By
As part of the DCAT Member Company Announcement Forum, held on March 21, 2022, at DCAT Week, the flagship event of the Drug, Chemical & Associated Technologies Association (DCAT), DCAT…

News from DCAT Week 2022: IDT Biologika Announcing $100-M-Plus Expansion Plan
By

By
IDT Biologika is investing more than EUR 100 million ($110 million) to expand drug-substance and drug- product manufacturing, visual inspection, and packaging capacities. Dr. Anne Bouchet, Senior Manager, IDT Biologika,…

News from DCAT Week 2022: Selkirk Pharma Expanding Injectables Mfg
By

By
Selkirk Pharma, a Spokane, Washington-based CDMO of injectable drugs, announced plans to expand manufacturing capacity by adding two additional production lines at its facility in Spokane. Selkirk specializes in the…